221 related articles for article (PubMed ID: 17262799)
1. Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS).
Eltoum IA; Roberson J
Cancer; 2007 Feb; 111(1):34-40. PubMed ID: 17262799
[TBL] [Abstract][Full Text] [Related]
2. Ambulatory care visits for Pap tests, abnormal Pap test results, and cervical cancer procedures in the United States.
Saraiya M; McCaig LF; Ekwueme DU
Am J Manag Care; 2010 Jun; 16(6):e137-44. PubMed ID: 20536271
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
4. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
[TBL] [Abstract][Full Text] [Related]
5. Impact of expected changes in national papanicolaou test volume on the cytotechnology labor market: an impending crisis.
Eltoum IA; Roberson J
Am J Clin Pathol; 2007 Oct; 128(4):665-70. PubMed ID: 17875520
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007.
Jain N; Euler GL; Shefer A; Lu P; Yankey D; Markowitz L
Prev Med; 2009 May; 48(5):426-31. PubMed ID: 19100762
[TBL] [Abstract][Full Text] [Related]
7. The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change.
Franco EL; Mahmud SM; Tota J; Ferenczy A; Coutlée F
Arch Med Res; 2009 Aug; 40(6):478-85. PubMed ID: 19853188
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
[TBL] [Abstract][Full Text] [Related]
9. Physician recommendation for papanicolaou testing among U.S. women, 2000.
Coughlin SS; Breslau ES; Thompson T; Benard VB
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
Hewitt M; Devesa SS; Breen N
Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
[TBL] [Abstract][Full Text] [Related]
11. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey.
Swan J; Breen N; Coates RJ; Rimer BK; Lee NC
Cancer; 2003 Mar; 97(6):1528-40. PubMed ID: 12627518
[TBL] [Abstract][Full Text] [Related]
12. Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia.
Brotherton JM; Mullins RM
Cancer Epidemiol; 2012 Jun; 36(3):298-302. PubMed ID: 22204834
[TBL] [Abstract][Full Text] [Related]
13. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
14. Psychological, behavioral, and interpersonal impact of human papillomavirus and Pap test results.
Kahn JA; Slap GB; Bernstein DI; Kollar LM; Tissot AM; Hillard PA; Rosenthal SL
J Womens Health (Larchmt); 2005 Sep; 14(7):650-9. PubMed ID: 16181021
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations?
Kepka D; Berkowitz Z; Yabroff KR; Roland K; Saraiya M
Sex Transm Infect; 2012 Oct; 88(6):433-5. PubMed ID: 22522751
[TBL] [Abstract][Full Text] [Related]
16. Comparison of knowledge and attitudes toward human papillomavirus, HPV vaccine, pap tests, and cervical cancer between US and Peruvian women.
Han CS; Ferris DG; Waller J; Tharp P; Walter J; Allmond L
J Low Genit Tract Dis; 2012 Apr; 16(2):121-6. PubMed ID: 22227842
[TBL] [Abstract][Full Text] [Related]
17. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006.
Tangka FK; O'Hara B; Gardner JG; Turner J; Royalty J; Shaw K; Sabatino S; Hall IJ; Coates RJ
Cancer Causes Control; 2010 Jul; 21(7):1081-90. PubMed ID: 20361353
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
19. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
20. [Cervical cancer screening and associated treatment costs in France].
Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
